The immunogenicity of humanized and fully human antibodies

Developmental Regulation of the Human Antibody Repertoirea

(2010) HARRY W. SCHROEDER et al.   Annals of the New York Academy of Sciences

Immune tolerance induction to enzyme-replacement therapy by co-administration of short-term, low-dose methotrexate in a murine Pompe disease model

(2010) A. Joseph et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Formulation and manufacturability of biologics

(2009) Steven J Shire   CURRENT OPINION IN BIOTECHNOLOGY

Follicular helper T cells as cognate regulators of B cell immunity

(2009) Louise J McHeyzer-Williams et al.   CURRENT OPINION IN IMMUNOLOGY

Plasticity of CD4+ T Cell Lineage Differentiation

(2009) Liang Zhou et al.   IMMUNITY

A Phase 2 Clinical Trial of Panitumumab Monotherapy in Japanese Patients with Metastatic Colorectal Cancer

(2009) K. Muro et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Nine lives: plasticity among T helper cell subsets: Figure 1.

(2009) Richard M. Locksley   JOURNAL OF EXPERIMENTAL MEDICINE

Dissociation of efficacy and cytokine release mediated by an Fc-modified anti-CD3 mAb in a chronic experimental autoimmune encephalomyelitis model

(2009) Nicole A. Belmar et al.   JOURNAL OF NEUROIMMUNOLOGY

Review: To What Extent are T Cells Tolerant to Immunoglobulin Variable Regions?

(2009) B. Bogen et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

A review of the international issues surrounding the availability and demand for diphtheria antitoxin for therapeutic use

(2009) K.S. Wagner et al.   VACCINE

Immunogenicity negatively influences the outcome of adalimumab treatment in Crohn’s disease

(2008) R. L. WEST et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: A randomized, double-blind, placebo-controlled, dose-ranging study

(2008) Jonathan Kay et al.   ARTHRITIS AND RHEUMATISM

Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double-blind, placebo-controlled, phase III trial

(2008) Robert D. Inman et al.   ARTHRITIS AND RHEUMATISM

Vaccines for lymphomas: Idiotype vaccines and beyond

(2008) Roch Houot et al.   BLOOD REVIEWS

Fully human antibodies from transgenic mouse and phage display platforms

(2008) Nils Lonberg   CURRENT OPINION IN IMMUNOLOGY

Prediction of immunogenicity: in silico paradigms, ex vivo and in vivo correlates

(2008) A DEGROOT et al.   CURRENT OPINION IN PHARMACOLOGY

Too dangerous to ignore: self-tolerance and the control of ignorant autoreactive T cells

(2008) Ian A Parish et al.   IMMUNOLOGY AND CELL BIOLOGY

Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose

(2008) Christine H. Chung et al.   NEW ENGLAND JOURNAL OF MEDICINE

The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes

(2008) S. Oak et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Consequence of neo-antigenicity of the 'altered self'

(2008) P. Eggleton et al.   RHEUMATOLOGY